Corrigendum: Inhibition of endothelial progenitor cells may explain the high cardiovascular event rate in patients with rheumatoid arthritis (QJM: An International Journal of Medicine (2018) 111 (525-529) DOI: 10.1093/qjmed/hcy099);Inhibition of endothelial progenitor cells may explain the high cardiovascular event rate in patients with rheumatoid arthritis

QJM: An International Journal of Medicine

Volumn 111, Issue 8, 2018, Pages 525-529

  Adawi, M ^a,b   Pastukh, N ^b   Saaida, G ^b   Sirchan, R ^a   Watad, A ^c   Blum, A ^a,b  

^a Department of Medicine and the Rheumatology Unit ^*  (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; C REACTIVE PROTEIN; PLATELET ENDOTHELIAL CELL ADHESION MOLECULE 1; VASCULOTROPIN RECEPTOR; BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DAS28; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; AGED; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; DISEASE PREDISPOSITION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR; STEM CELL; VASCULAR ENDOTHELIUM;

AGED; ARTHRITIS, RHEUMATOID; BIOMARKERS; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DISEASE SUSCEPTIBILITY; ENDOTHELIAL PROGENITOR CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STEM CELLS; ULTRASONOGRAPHY;

EID: 85055106213     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcy204     Document Type: Erratum

References (41)

1. Peters MJL, Symmons DPM, McCarey D, Dijkmans BAC, Nicola P, Kvien TK, et al. EULAR evidence based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 2010, 69:325-31.
2. Meune C, Touzé E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: A systemic review and meta-analysis of cohort studies. Rheumatology 2009, 48:1309-13.
3. Avi~na-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum 2008, 59:1690-7.
4. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003, 107:1303-7.
5. Ku IA, Imboden JB, Hsue PY, Ganz P. Rheumatoid arthritis: Model of systemic inflammation driving atherosclerosis. Circ J 2009, 73:977-85.
6. Gossec L, Salejan F, Nataf H, Nguyen M, Gaud-Listrat V, Hudry C, et al. Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: An observational study of 110 rheumatoid arthritis patients. Arthritis Care Res 2013, 65:712-7.
7. Dessein PH, Semb AG. Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced Ann Rheum Dis 2013, 72:1743-6.
8. Westlake SL, Colebatch AN, Baird J, Curzen N, Kiely P, Quinn M, et al. Tumor necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: A systemic literature review. Rheumatology 2011, 50:518-31.
9. Barnabe C, Martin BJ, Ghali WA. Systematic review and metaanalysis: Anti-tumor necrosis factor alpha therapy and cardiovascular events ini rheumatoid arthritis. Arthritis Care Res 2011, 63:522-9.
10. Roman MJ, Moeller E, Davis A, Paget SA, Crow MK, Lockshin MD, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006, 144:249-56.
11. Del Rincón I, Williams K, Stern MP, Freeman GL, O'Leary DH, Escalante A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003, 48:1833-40.
12. Dessein PH, Joffe BI, Singh S. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2005, 7:R634-43.
13. Hü rlimann D, Forster A, Noll G, Enseleit F, Chenevard R, Distler O, et al. Anti-tumor necrosis factor alpha treatment improves endothelial function in patients with rheumatoid arthritis. Circulation 2002, 106:2184-7.
14. Van Doornum S, McColl G, Jenkins A, Green DJ, Wicks IP. Screening for atherosclerosis in patients with rheumatoid arthritis: Comparison of two in vivo tests of vascular function. Arthritis Rheum 2003, 48:72-80.
15. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, cardiovascular risk. N Engl J Med 2003, 348:593-600.
16. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005, 111:204-11.
17. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science 1997, 275:964-7.
18. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow derived endothelial progenitor cells. EMBO J 1999, 18:3964-72.
19. Ito H, Rovira II, Bloom ML, Takeda K, Ferrans VJ, Quyyumi AA, et al. Endothelial progenitor cells as putative targets for angiostatin. Cancer Res 1999, 59:5875-7.
20. Chatterjee Adhikari M, Guin A, Chakraborty S, Sinhamahapatra P, Ghosh A. Subclinical atherosclerosis and endothelial dysfunction in patients with early rheumatoid arthritis as evidenced by measurement of carotid intima media thickness and flow mediated vasodilatation: An observational study. Semin Arthritis Rheum 2012, 41:669-75.
21. Aubry MC, Riehle DL, Edwards WD, Maradit-Kremers H, Roger VL, Sebo TJ, et al. lymphocytes in plaque and adventitia of coronary arteries in two patients with rheumatoid arthritis and coronary atherosclerosis: Preliminary observations. Cardiovasc Pathol 2004, 13:233-6.
22. Dimitroulas T, Hodson J, Sandoo A, Smith J, Kitas GD. Endothelial injury in rheumatoid arthritis: A crosstalk between dimethylarginines and systemic inflammation. Arthritis Res Ther 2017, 19:32-5.
23. Mullick OS, Bhattacharya R, Bhattacharyya K, Sarkar RN, Das A, Chakraborty D, et al. Lipid profile and its relationship with endothelial dysfunction and disease activity in patients of early rheumatoid arthritis. Indian J Rheumatol 2014, 9:9-13.
24. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum2002, 31:355-60.
25. Gonzalez-Gay MA, Gonzalez-Juanatey C, Ollier WE. Endothelial dysfunction in rheumatoid arthritis: Influence of HLA-DRB1 alleles. Autoimmun Rev 2004, 3:301.
26. Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: Results of eighteen years of follow up from the early rheumatoid arthritis study. Arthritis Rheum 2007, 56:1408-16.
27. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
28. Schmidt-Lucke C, Rö ssig L, Fichtlscherer S, Vasa M, Britten M, Kämper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111:2981-7.
29. Mikirova NA, Jackson JA, Hunninghake R, Kenyon J, Chan KW, Swindlehurst CA, et al. Circulating endothelial progenitor cells: A new approach to anti-aging medicine J Transl Med 2009, 7:106.
30. Grisar JC, Haddad F, Gomari FA, Wu JC. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: From biomarker to therapeutic agent. Biomark Med 2011, 5: 731-44.
31. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-7.
32. Tyner SD, Venkatachalam S, Choi J, Jones S, Ghebranious N, Igelmann H, et al. p53 mutant mice that display early ageingassociated phenotypes. Nature 2002, 415:45-53.
33. Geiger H, Van Zant G. The aging of lympho-hematopoietic stem cells. Nat Immunol 2002, 3:329-33.
34. Rodŕguez-Carrio J, de Paz B, López P, Prado C, Alperi-López M, Ballina-Garcá FJ, et al. IFN a serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients. PLoS One 2014, 9:e86069.
35. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, et al. HLADRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 2003, 114:647-52.
36. Bergholm R, Leirisalo-Repo M, Vehkavaara S, Mä kimattila S, Taskinen MR, Yki-Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Throm Vasc Biol 2002, 22:1637-41.
37. Garg N, Syngle A, Verma I, Krishan P. Endothelial progenitor cells as cardiovascular surrogate markers in seropositive rheumatoid arthritis. Int J Rheumatol Clin Immunol 2015, 3:1-6.
38. Park YJ, Kim JY, Park J, Choi JJ, Kim WU, Cho CS. Bone erosion is associated with reduction of circulating endothelial progenitor cells and endothelial dysfunction. Arthritis Rheumatol 2014, 66: 1450-60.
39. Lo Gullo A, Mandraffino G, Imbalzano E, Mamone F, Aragona CO, D'Ascola A, et al. Toll like receptor 3 and interleukin 1b expression in CD34\+ cells frompatients with rheumatoid arthritis: Association with inflammation and vascular involvement. Clin Exp Rheumatol 2014, 32:922-9.
40. Lo Gullo A, Mandraffino G, Sardo MA, D'Ascola A, Mamone F, Loddo S, et al. Circulating progenitor cells in rheumatoid arthritis: Association with inflammation and oxidative stress. Scand J Rheumatol 2014, 43:184-93.
41. Adawi M, Watad A, Bragazzi NL, Amital H, Golan S, Rizak S, et al. Endothelial Function in Rheumatoi Arthritis. QJM 2018, doi:10.1093/qjmed/hcy010.